These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3126408

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa.
    Deleu D, Ebinger G, Michotte Y.
    Eur J Clin Pharmacol; 1991; 41(5):453-8. PubMed ID: 1761073
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease.
    Sage JI, Schuh L, Heikkila RE, Duvoisin RC.
    Clin Neuropharmacol; 1988 Feb; 11(1):36-44. PubMed ID: 3349496
    [Abstract] [Full Text] [Related]

  • 7. Impaired absorption of oral levodopa: a major cause for response fluctuations in Parkinson's disease.
    Djaldetti R, Ziv I, Melamed E.
    Isr J Med Sci; 1996 Dec; 32(12):1224-7. PubMed ID: 9007159
    [Abstract] [Full Text] [Related]

  • 8. Irregular gastrointestinal drug absorption in Parkinson's disease.
    Nyholm D, Lennernäs H.
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):193-203. PubMed ID: 18248312
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Using liquid levodopa in the treatment of Parkinson's disease. A practical guide.
    Kurth MC.
    Drugs Aging; 1997 May; 10(5):332-40. PubMed ID: 9143854
    [Abstract] [Full Text] [Related]

  • 13. [Intraduodenal infusion of levodopa].
    Valldeoriola F, Cámara A.
    Rev Neurol; 2010 Jul 01; 51(1):41-8. PubMed ID: 20568067
    [Abstract] [Full Text] [Related]

  • 14. Variations in L-dopa absorption. Report of a parkinsonian patient with high plasma dopa concentration after therapeutical L-dopa dose.
    Granerus AK, Jagenburg R, Rödjer S, Svanborg A.
    Acta Med Scand; 1974 Dec 01; 196(6):459-63. PubMed ID: 4456974
    [No Abstract] [Full Text] [Related]

  • 15. Patterns of clinical response and plasma dopa levels in Parkinson's disease.
    Tolosa ES, Martin WE, Cohen HP, Jacobson RL.
    Neurology; 1975 Feb 01; 25(2):177-83. PubMed ID: 1167646
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.
    Nyholm D.
    Expert Rev Neurother; 2006 Oct 01; 6(10):1403-11. PubMed ID: 17078781
    [Abstract] [Full Text] [Related]

  • 18. Novel levodopa formulations in the treatment of Parkinson's disease.
    Pilleri M, Antonini A.
    Expert Rev Neurother; 2014 Feb 01; 14(2):143-9. PubMed ID: 24428803
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.